These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2208796)

  • 1. Sera with high levels of anti-smooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeleton proteins.
    Dighiero G; Lymberi P; Monot C; Abuaf N
    Clin Exp Immunol; 1990 Oct; 82(1):52-6. PubMed ID: 2208796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA.
    Leibovitch L; George J; Levi Y; Bakimer R; Shoenfeld Y
    Immunol Lett; 1995 Dec; 48(2):129-32. PubMed ID: 8719111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-smooth muscle antibodies (ASMAs) and anti-cytoskeleton antibodies (ACTAs) in liver diseases: a comparison of classical indirect immunofluorescence with ELISA.
    Zamanou A; Tsirogianni A; Terzoglou C; Balafas A; Economidou I; Lymberi P
    J Clin Lab Anal; 2002; 16(4):194-201. PubMed ID: 12112392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance.
    Kurki P; Miettinen A; Linder E; Pikkarainen P; Vuoristo M; Salaspuro MP
    Gut; 1980 Oct; 21(10):878-84. PubMed ID: 7002738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.
    Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME
    Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to hepatocyte membrane antigens in chronic liver disease: detection by immunofluorescence after Bouin's fixation.
    Lee WM; Shelton LL; Galbraith RM
    J Histochem Cytochem; 1983 Oct; 31(10):1246-9. PubMed ID: 6350436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of antimitochondrial antibodies with the M2-M4 pattern by immunofluorescence as assessed by Western immunoblotting and enzyme linked immunosorbent assay.
    Fusconi M; Ghadiminejad I; Bianchi FB; Baum H; Bottazzo GF; Pisi E
    Gut; 1988 Apr; 29(4):440-7. PubMed ID: 2453397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques.
    Gruber R; Felber E; Pape GR; Höchtlen-Vollmar W; Riethmüller G
    J Clin Lab Anal; 1994; 8(5):284-92. PubMed ID: 7807283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.
    Villalta D; Bizzaro N; Da Re M; Tozzoli R; Komorowski L; Tonutti E
    Autoimmunity; 2008 Feb; 41(1):105-10. PubMed ID: 18176872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lipoyl synthetic octadecapeptide of dihydrolipoamide acetyltransferase specifically recognized by anti-M2 autoantibodies in primary biliary cirrhosis.
    Tuaillon N; Andre C; Briand JP; Penner E; Muller S
    J Immunol; 1992 Jan; 148(2):445-50. PubMed ID: 1729364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease.
    Kurki P; Gripenberg M; Teppo AM; Salaspuro M
    Liver; 1984 Apr; 4(2):134-8. PubMed ID: 6610088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody binding and inhibition of pyruvate dehydrogenase (PDH) in sera from patients with primary biliary cirrhosis.
    Sundin U
    Clin Exp Immunol; 1990 Aug; 81(2):238-43. PubMed ID: 2387091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoskeleton antibodies in chronic active hepatitis, primary biliary cirrhosis, and alcoholic liver disease.
    Kurki P; Miettinen A; Salaspuro M; Virtanen I; Stenman S
    Hepatology; 1983; 3(3):297-302. PubMed ID: 6341195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
    Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
    Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune liver diseases.
    Manns MP; Nakamura RM
    Clin Lab Med; 1988 Jun; 8(2):281-301. PubMed ID: 3284697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heterogenicity of mitochondrial antibodies (author's transl)].
    Berg PA; Binder T; Lindner H; Bannaski H; Maas D; Henning H; Brügel H
    Dtsch Med Wochenschr; 1975 May; 100(20):1123-7. PubMed ID: 1126299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of cross-reactivity between antibody against smooth muscle and antibodies to measles virus in sera from patients with chronic active hepatitis.
    Sommer AI; Haukenes G
    J Clin Pathol; 1982 Dec; 35(12):1388-91. PubMed ID: 7174849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-M4 antibodies measured by a sulphite oxidase ELISA in patients with both anti-centromere and anti-M2 antibodies.
    Bunn CC; McMorrow M
    Clin Exp Immunol; 1995 Oct; 102(1):131-6. PubMed ID: 7554379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELISA assay for IgG autoantibody to G-actin: comparison of chronic active hepatitis and acute viral hepatitis.
    Bretherton L; Brown C; Pedersen JS; Toh BH; Clarke FM; Mackay IR; Gust ID
    Clin Exp Immunol; 1983 Mar; 51(3):611-6. PubMed ID: 6342886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of autoimmunity in cryptogenic chronic hepatitis.
    Provenzano G; Marino L; Craxì A
    Allergol Immunopathol (Madr); 1991; 19(3):119-22. PubMed ID: 1799170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.